Champlain Investment Partners LLC Has $272.70 Million Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Champlain Investment Partners LLC grew its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 13.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 682,420 shares of the biotechnology company’s stock after purchasing an additional 83,265 shares during the quarter. Axon Enterprise makes up about 1.7% of Champlain Investment Partners LLC’s investment portfolio, making the stock its 10th largest position. Champlain Investment Partners LLC’s holdings in Axon Enterprise were worth $272,695,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Blue Trust Inc. grew its position in Axon Enterprise by 987.5% during the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after acquiring an additional 79 shares during the last quarter. Quent Capital LLC raised its holdings in Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after buying an additional 75 shares during the last quarter. Asset Dedication LLC purchased a new stake in Axon Enterprise during the 2nd quarter valued at $47,000. Planning Capital Management Corp grew its holdings in Axon Enterprise by 83.3% in the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after acquiring an additional 55 shares during the last quarter. Finally, Friedenthal Financial purchased a new position in shares of Axon Enterprise in the third quarter valued at about $51,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 21,834 shares of the firm’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the sale, the insider now directly owns 154,394 shares of the company’s stock, valued at $91,691,508.72. This trade represents a 12.39 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, President Joshua Isner sold 20,000 shares of the company’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00. Following the completion of the transaction, the president now directly owns 208,166 shares of the company’s stock, valued at approximately $126,179,820.90. This trade represents a 8.77 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 330,256 shares of company stock worth $131,338,820. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Stock Up 0.9 %

AXON stock opened at $636.95 on Friday. The business’s 50-day moving average price is $458.43 and its 200-day moving average price is $365.54. The stock has a market cap of $48.57 billion, a P/E ratio of 164.59, a PEG ratio of 18.89 and a beta of 0.94. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a twelve month low of $224.28 and a twelve month high of $641.20.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. The Goldman Sachs Group increased their target price on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Barclays lifted their price objective on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Craig Hallum upped their target price on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. Robert W. Baird lifted their price target on shares of Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Finally, JMP Securities boosted their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday, October 31st. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $427.83.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.